Patents by Inventor James B. Wechuck

James B. Wechuck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIGH-TRANSDUCING HSV VECTORS
    Publication number: 20240158809
    Abstract: Disclosed herein are high transducing replication defective herpes simplex virus (HSV) vectors of McKrae strain.
    Type: Application
    Filed: July 26, 2023
    Publication date: May 16, 2024
    Applicant: PeriphaGen, Inc.
    Inventors: David M. Krisky, James B. Wechuck
  • High-transducing HSV vectors
    Patent number: 11753653
    Abstract: Disclosed herein are high transducing replication defective herpes simplex virus (HSV) vectors of McKrae strain.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: September 12, 2023
    Assignee: Periphagen, Inc.
    Inventors: David M. Krisky, James B. Wechuck, James R. Goss
  • HSV vectors for delivery of NT3 and treatment of CIPN
    Patent number: 10799560
    Abstract: Disclosed herein are compositions and methods for treating neuropathy, embodiments, HSV vectors are provided comprising nucleic acid molecules encoding neurotrophins, such as neurotrophin 3 (NT3).
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: October 13, 2020
    Assignee: Periphagen, Inc.
    Inventors: David M. Krisky, James B. Wechuck, James R. Goss
  • HSV VECTORS FOR DELIVERY OF NT3 AND TREATMENT OF CIPN
    Publication number: 20200206314
    Abstract: Disclosed herein are compositions and methods for treating neuropathy, embodiments, HSV vectors are provided comprising nucleic acid molecules encoding neurotrophins, such as neurotrophin 3 (NT3).
    Type: Application
    Filed: March 24, 2017
    Publication date: July 2, 2020
    Applicant: PeriphaGen, Inc.
    Inventors: David M. Krisky, James B. Wechuck, James R. Goss
  • HIGH-TRANSDUCING HSV VECTORS
    Publication number: 20200199618
    Abstract: Disclosed herein are high transducing replication defective herpes simplex virus (HSV) vectors of McKrae strain.
    Type: Application
    Filed: March 24, 2017
    Publication date: June 25, 2020
    Applicant: PeriphaGen, Inc.
    Inventors: David M. Krisky, James B. Wechuck, James R. Goss